Table 2.
Drug store | General shop | ||
Treatment‡ | % (95% CI) | % (95% CI) | P* |
N | 29 | 460 | |
Child aged two years with uncomplicated malaria | |||
Referral to health facility | 3 (0–18) | 34 (30–39) | 0.001 |
Antipyretic | 55 (36–74) | 31 (27–35) | 0.007 |
Antimalarial | 90 (73–98) | 32 (28–36) | <0.001 |
- SP | 66 (46–82) | 12 (9–16) | <0.001 |
- SP + PCM | 35 (18–54) | 5 (3–7) | <0.001 |
- SP correct dose | 52 (33–71) | 3 (2–5) | <0.001 |
- SP correct dose + PCM | 31 (15–51) | 1 (0–2) | <0.001 |
Adult with uncomplicated malaria | |||
Referral to HF† | 0 (0–12) | 24 (20–28) | 0.003 |
Antipyretic | 55 (36–74) | 44 (39–49) | 0.237 |
Antimalarial | 93 (77–99) | 54 (49–58) | <0.001 |
- SP | 79 (60–92) | 35 (31–40) | <0.001 |
- SP + PCM | 48 (29–68) | 16 (13–19) | <0.001 |
- SP correct dose | 76 (57–90) | 29 (25–33) | <0.001 |
- SP correct dose + PCM | 45 (26–64) | 14 (11–18) | <0.001 |
SP = Sulphadoxine-pyrimethamine; PCM = Paracetamol.
* Wilcoxon rank sign test.
‡ Double-mentioning possible.
† one-sided, 97.5% confidence interval.